DABRAFENIB vs ENZALUTAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs ENZALUTAMIDE: Safety Overview
| Metric | DABRAFENIB | ENZALUTAMIDE |
|---|---|---|
| Total FAERS Reports | 19,305 | 49,270 |
| Deaths Reported | 4,165 | 9,676 |
| Death Rate | 21.6% | 19.6% |
| Hospitalizations | 5,325 | 9,282 |
| Average Patient Age | 58.3 yrs | 76.0 yrs |
| % Female Patients | 48.0% | 0.6% |
| FDA Approval Date | Mar 16, 2023 | Apr 22, 2022 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Astellas Pharma US, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |